CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 18 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $46,000 | -25.8% | 22,031 | 0.0% | 0.03% | -17.9% |
| Q1 2022 | $62,000 | -39.8% | 22,031 | 0.0% | 0.04% | -39.1% |
| Q4 2021 | $103,000 | +74.6% | 22,031 | 0.0% | 0.06% | +68.4% |
| Q3 2021 | $59,000 | -6.3% | 22,031 | 0.0% | 0.04% | -7.3% |
| Q2 2021 | $63,000 | -6.0% | 22,031 | 0.0% | 0.04% | -14.6% |
| Q1 2021 | $67,000 | +3.1% | 22,031 | 0.0% | 0.05% | -7.7% |
| Q4 2020 | $65,000 | – | 22,031 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Financial Planning, Inc. | 22,031 | $59,000 | 0.04% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 176,185 | $472,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,987 | $435,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 162,217 | $429,000 | 0.00% |
| Renaissance Technologies | 664,564 | $1,781,000 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $8,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 696,654 | $1,881,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 16,246 | $44,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,614 | $13,000 | 0.00% |
| MORGAN STANLEY | 3,172 | $8,000 | 0.00% |